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Background: Associations between medical conditions and pancreatic cancer risk are controversial and are thus evaluated in a
study conducted during 1994–1998 in Minnesota.
Methods: Cases (n¼ 215) were ascertained from hospitals in the metropolitan area of the Twin Cities and the Mayo Clinic.
Controls (n¼ 676) were randomly selected from the general population and frequency matched to cases by age and sex. The
history of medical conditions was gathered with a questionnaire during in-person interviews. Odds ratios (OR) and 95% confidence
intervals (95% CI) were estimated using unconditional logistic regression.
Results: After adjustment for confounders, subjects who had cholecystectomy or gallstones experienced a significantly higher risk
of pancreatic cancer than those who did not (OR (95% CI): 2.11 (1.32–3.35) for cholecystectomy and 1.97 (1.23–3.12) for gallstones),
whereas opposite results were observed for tonsillectomy (0.67 (0.48–0.94)). Increased risk associated with cholecystectomy was
the greatest when it occurred p2 years before the cancer diagnosis (5.93 (2.36–15.7)) but remained statistically significant when
that interval was X20 years (2.27 (1.16–4.32)).
Conclusions: Cholecystectomy, gallstones, and tonsillectomy were associated with an altered risk of pancreatic cancer. Our study
suggests that cholecystectomy increased risk but reverse causality may partially account for high risk associated with recent
cholecystectomy.
Pancreatic cancer is the fourth leading cause of cancer death in the
US (American Cancer Society, 2013). The International Agency for
Research on Cancer has estimated that 138 100 men and 127 900
women died from this malignancy worldwide in 2008 (Jemal et al,
2011). Despite high mortality, pancreatic cancer etiology virtually
remains obscure (Olson and Kurtz, 2013). Although cigarette
smoking has been established as a risk factor, it accounts for only
about 25–30% of the variation of the disease (Silverman et al, 1999;
Hassan et al, 2007). It is apparent that more risk factors need to be
identified to enable the primary prevention of pancreatic cancer.
Cholecystectomy, gallstones (cholelithiasis), and tonsillectomy
are common medical conditions/procedures (Lin and Kessler,
1981; Gullo et al, 1996). To date, at least 13 epidemiologic studies
have investigated the associations of cholecystectomy and/or
gallstones with pancreatic cancer risk. The results obtained from
these studies are overall conflicting (Lin and Kessler, 1981; Ekbom
et al, 1996; Gullo et al, 1996; Chow et al, 1999; Coughlin et al, 2000;
Silverman, 2001; Talamini et al, 2001; Ye et al, 2001; Lin et al, 2002;
Schernhammer et al, 2002; Stolzenberg-Solomon et al, 2002;
Hassan et al, 2007; Lipworth et al, 2011). Significantly increased
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risk associated with cholecystectomy and/or gallstones was
observed in one case-control study (Silverman, 2001) and four
cohort studies (Ekbom et al, 1996; Chow et al, 1999; Coughlin et al,
2000; Lin et al, 2002). However, null associations were found
among four case-control studies (Lin and Kessler, 1981; Gullo et al,
1996; Hassan et al, 2007; Lipworth et al, 2011) and four cohort
studies (Talamini et al, 2001; Ye et al, 2001; Schernhammer et al,
2002; Stolzenberg-Solomon et al, 2002). Cholecystectomy and/or
gallstones may occur as a manifestation of subclinical pancreatic
cancer (Hassan et al, 2007; Lipworth et al, 2011). Therefore, one of
the potential reasons for these discrepant findings is that many
previous studies failed to consider the time interval between
diagnosis of medical conditions and of pancreatic cancer (Lin and
Kessler, 1981; Ekbom et al, 1996; Chow et al, 1999; Coughlin et al,
2000; Lin et al, 2002; Stolzenberg-Solomon et al, 2002).
Tonsils are organs of lymphoid tissue that constitute the first
line of defense of the immune system against invading pathogens.
Tonsillectomy is usually performed following repeated occurrence
of acute tonsillitis and airway obstruction (Vestergaard et al, 2010).
Data are scarce on whether tonsillectomy has any influence on
pancreatic cancer risk (Lin and Kessler, 1981). The present study
thereby sought to evaluate cholecystectomy, gallstones, and
tonsillectomy in relation to the risk of this fatal disease in a
population-based case-control study in Minnesota.
MATERIALS AND METHODS
Study population. The present study was performed within a
case-control study conducted from April 1994 to September 1998
in Minnesota, and the design and methods of this epidemiologic
study have been described in detail elsewhere (Gross et al, 1999;
Anderson et al, 2002). Briefly, the source cohort was The Upper
Midwest of the US. Cases were subjects with newly diagnosed
cancer of the exocrine pancreas (International Classification of
Disease for Oncology, third edition, code C25), confirmed by
histology, cytology, or clinical symptoms consistent with pancreas
cancer. All pathology reports of potential cases were reviewed by a
pathologist or confirmed through the Minnesota Cancer Surveil-
lance System for eligibility. Cases were ascertained from all
hospitals in the seven-county metropolitan area of the Twin Cities
(Minneapolis and St Paul), Minnesota, and the Mayo Clinic (only
cases residing in The Upper Midwest were recruited from the
Mayo Clinic). A rapid case-ascertainment system was employed to
recruit cases because pancreatic cancer is rapidly fatal. As a result,
the median number of days between diagnosis and first contact for
the study was only 13 days for the cases enroled in the study.
Pancreatic cancer cases were eligible if they were 20 years of age or
older, spoke English, and were mentally competent. Of 460 eligible
cases identified, 202 did not participate in the study due to death
before contact or interview (n¼ 85), refusal of cases (n¼ 79),
refusal of physicians (n¼ 31), and inability to contact cases (n¼ 7).
Therefore, 258 cases completed the study; thus the response rate
was 56.1%.
Controls were randomly selected from the seven-county
metropolitan area of the Twin Cities. While controls aged 20–64
years were identified from the drivers’ license and state identity
card database, those aged 65 years or older were ascertained from
US Health Care Financing Administration (now Centers for
Medicare & Medicaid Services) records. Controls were frequency
matched to cases by age (within 5 years) and sex. Race was not
used as a matching variable because the vast majority of study
subjects (97.2%) were of European descent. Inclusion criteria for
controls were the same as those for cases, disallowing diagnosis of
pancreatic cancer. Of 1141 eligible controls identified, 676
participated in the study, which yields a response rate of 59.2%.
After excluding 43 cases without data on all three medical
conditions considered, 215 cases (including 72 cases recruited from
the Mayo Clinic) and 676 controls are available for the analysis of
the present study.
Data collection. The study protocol was approved by the
Institutional Review Boards of the University of Minnesota and
the Mayo Clinic. Before interview, written, informed consent was
obtained from all cases and controls. All participants were
interviewed in person with a basic questionnaire and a food
frequency questionnaire (FFQ). The basic questionnaire elicited
information on demographics, socioeconomics, physical activity,
cigarette smoking, and medical history. Both occupational and
leisure-time activities were evaluated. The participants were asked
to report the number of hours per week they usually spent on light,
moderate, and heavy activities in the year before pancreatic cancer
diagnosis for cases or the past year for controls. The total amount
of physical activity (h per week) was calculated by summing the
three levels of the activities. Data on the status (never, former, and
current), amount (cigarettes per day), and duration (years) of
cigarette smoking were collected from participants.
Information on cholecystectomy, gallstones, tonsillectomy, and
diabetes was collected. If a subject reported a history of one or
more of these medical conditions, the year of diagnosis of the
condition(s) (except gallstones) was also recorded. A slightly
modified version of the Willett FFQ was used to assess diet during
the year before pancreatic cancer diagnosis for cases or the past
year for controls (Willett et al, 1987). This dietary assessment
instrument covered 153 items of food or food groups frequently
consumed by the general population in the US and also contained
questions on alcohol intake (serving per week). Dietary intakes of
energy and nutrients were calculated by multiplying the amount in
a pre-specified portion size of each food item by the reported
average frequency of consumption and summing over all food
items. The amounts of energy and nutrients for the portion size of
each of the food items surveyed were estimated on the basis of a
nutrient database developed for the Minnesota Colon Cancer
Prevention Research Unit studies.
Statistical analysis. Pancreatic cancer risk, in relation to each of
the three medical conditions considered, was estimated as odds
ratios (OR) and 95% confidence intervals (95% CI) by uncondi-
tional logistic regression. Subjects without a given condition were
treated as the reference group to evaluate risk for those with that
condition. Crude and multivariable-adjusted ORs were calculated
for each of the three conditions examined. The confounders
initially adjusted in the regression models include age, sex, race
(white, black, and other), education (three levels), cigarette
smoking (never, former, and current), alcohol drinking (serving
per week), physical activity (h per week), energy intake, and
diabetes (yes, no). Education, alcohol drinking, and energy intake
were dropped from the final models because they did not
substantively alter ORs (i.e., o10%). Evaluating whether energy
intake and alcohol drinking were real confounders was confined to
167 cases and 554 controls whose diet was assessed with the FFQ
described above.
The diagnosis of gallstones or need for cholecystectomy may be
simply driven by clinical manifestation of an insidious pancreatic
cancer (Schernhammer et al, 2002). The availability of data on the
year of cholecystectomy allows us to evaluate whether reverse
causality exists between this condition and pancreatic cancer risk.
Specifically, risk was estimated by the time interval between the
year of cholecystectomy and the year of cancer diagnosis (i.e., no
cholecystectomy vs p2 years, 3–19 years, and X20 years).
A P-value of o0.05 (two-sided) was considered statistically
significant. All statistical analyses were conducted with the SAS
(version 9.3; SAS Institute Inc., Cary, NC, USA).
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RESULTS
Characteristics of cases and controls are shown in Table 1. Mean
age was 66.0 years for both cases and controls. No statistically
significant differences in age and sex existed between cases and
controls, suggesting the success of frequency-matching controls to
cases by these two variables. Cases were less physically active but
more likely to be a smoker or have diabetes than controls (all
Po0.05). Cholecystectomy and gallstones were more common in
cases than in controls (both Po0.001), whereas the proportion of
tonsillectomy was not statistically different between cases and
controls. Of 118 subjects diagnosed with gallstones, 91 (77%)
received cholecystectomy.
After adjustment for age, sex, race, smoking status, physical
activity, and diabetes, both cholecystectomy and gallstones were
associated with a significantly increased risk of pancreatic cancer
(OR (95% CI): 2.11 (1.32–3.35) for cholecystectomy and 1.97
(1.23–3.12) for gallstones) (Table 2). Compared with subjects
without a history of cholecystectomy, the adjusted OR (95% CI)
was 5.93 (2.36–15.7), 1.31 (0.57–2.75), and 2.27 (1.16–4.32) for
those whose cholecystectomy was conductedp2 years, 3–19 years,
and X20 years before diagnosis of pancreatic cancer, respectively
(Table 3). Subjects who received a tonsillectomy experienced a 33%
lower risk than those who did not (OR (95% CI): 0.67 (0.48–0.94))
(Table 2).
After excluding 17 subjects undergoing cholecystectomy for
reasons other than gallstones, an increased risk of pancreatic
cancer associated with this surgery materially remained unchanged
(OR (95% CI): 1.92 (1.16–3.14)). Additional adjustment for the
participating center (the Twin Cities vs the Mayo Clinic) somewhat
attenuated elevated risk associated with cholecystectomy
performed X20 years before diagnosis of pancreatic cancer (OR
(95% CI): 1.91 (0.81–3.77)), but did not markedly changed other
ORs observed for cholecystectomy, gallstones, or tonsillectomy.
Controlling for cigarette smoking by using pack-years did not
result in substantive changes in obtained risk estimates.
DISCUSSION
In the present study, cholecystectomy and gallstones were
associated with a significantly increased risk of pancreatic cancer
after adjustment for confounders, whereas tonsillectomy was
associated with a significantly decreased risk. Furthermore,
elevated risk was the highest for recent cholecystectomy (p2
years before cancer diagnosis) but remained statistically significant
for remote cholecystectomy (X20 years).
Current epidemiologic evidence for associations between
selected medical conditions and pancreatic cancer risk is
controversial (Olson, 2012). Of 13 studies that have evaluated
cholecystectomy and/or gallstones in relation to the occurrence of
this malignancy (Lin and Kessler, 1981; Ekbom et al, 1996; Gullo
et al, 1996; Chow et al, 1999; Coughlin et al, 2000; Silverman, 2001;
Talamini et al, 2001; Ye et al, 2001; Lin et al, 2002; Schernhammer
et al, 2002; Stolzenberg-Solomon et al, 2002; Hassan et al, 2007;
Lipworth et al, 2011), four studies reported an increased risk for
subjects with a history of cholecystectomy (Ekbom et al, 1996;
Coughlin et al, 2000; Silverman, 2001; Lin et al, 2002). A 20%
elevated risk was found in the American Cancer Society Cancer
Prevention Study II (Coughlin et al, 2000). However, this positive
association was not found in six other studies (Lin and Kessler,
1981; Gullo et al, 1996; Talamini et al, 2001; Ye et al, 2001;
Schernhammer et al, 2002; Hassan et al, 2007). It should be
pointed out that the time interval between cholecystectomy and
pancreatic cancer diagnosis was not considered in most previous
studies (Lin and Kessler, 1981; Ekbom et al, 1996; Gullo et al, 1996;
Chow et al, 1999; Coughlin et al, 2000; Silverman, 2001; Talamini
et al, 2001; Ye et al, 2001; Lin et al, 2002; Schernhammer et al,
2002; Stolzenberg-Solomon et al, 2002; Hassan et al, 2007;
Lipworth et al, 2011). In a large case-control study conducted in
the US, a significantly increased risk was found for subjects with
cholecystectomy performed 2 years or less before diagnosis of
pancreatic cancer (OR (95% CI): 3.9 (2.4–6.4)), but this positive
association disappeared when analysis was confined to subjects
with this condition over 2 years before cancer diagnosis (OR (95%
CI): 1.1 (0.9–1.8)) (Hassan et al, 2007). The results obtained from
that US study were similar to those in a Swedish study (Ye et al,
2001). In addition, a descriptive epidemiologic study did not report
a significant increase in pancreatic cancer incidence in the US
during 1992–1996 after the widespread adoption of laparoscopic
cholecystectomy in 1991, although a long-term effect of this
medical event could not be entirely ruled out (Urbach et al, 2001).
We found that the apparent effect of cholecystectomy was the
strongest when it occurred 2 years or less before the cancer
diagnosis, became substantially weaker when that interval was
longer than 2 years, but was still statistically significant even when
Table 1. Characteristics of cases and controls in a population-based case-






Age (years)c 66.0 (11.4) 66.0 (12.5) 0.99
Sex
Male 125 (58.4%) 381 (56.4%) 0.60
Female 89 (41.6%) 295 (43.6%)
Race
White 201 (93.9%) 664 (98.2%) 0.002
Black 9 (4.2%) 5 (0.7%)
Other 4 (1.9%) 7 (1.1%)
Cigarette smoking
Never smoker 80 (38.1%) 317 (46.9%) 0.046
Former smoker 96 (45.7%) 281 (41.6%)
Current smoker 34 (16.2%) 78 (11.5%)
Physical activity (h per week)c 36.7 (22.9) 44.3 (22.0) o0.0001
Diabetes
Yes 51 (25.6%) 52 (7.7%) o0.0001
No 148 (74.4%) 624 (92.3%)
Cholecystectomy
Yes 48 (23.7%) 72 (10.7%) o0.0001
No 155 (76.4%) 604 (89.4%)
Gallstones
Yes 42 (21.8%) 78 (11.6%) 0.0003
No 151 (78.2%) 597 (88.4%)
Tonsillectomy
Yes 100 (48.3%) 374 (55.4%) 0.073
No 107 (51.7%) 301 (44.6%)
aData were missing for cases (n) on sex (1), race (1), cigarette smoking (5), physical activity
(23), diabetes (16), cholecystectomy (12), gallstones (22), and tonsillectomy (8), and controls
(n) on physical activity (3), gallstones (1), and tonsillectomy (1).
b72 cases were recruited from the Mayo Clinic.
cValues given are means (s.d.).
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that interval was 20 years or more. Our results regarding time since
cholecystectomy were consistent with those of a multi-center case-
control study (Silverman et al, 1999). Reverse causality may
partially account for high risk associated with recent cholecys-
tectomy because this surgery might be performed for the gallstones
or other gallbladder diseases that appeared as clinical symptoms
and signs of an early-stage pancreatic cancer. Asymptomatic
gallstones may also be incidentally discovered during the
diagnostic process for subjects presenting with abdominal pain
and incorrectly attributed as the cause that is really a result of
cancer. However, our observation of significantly elevated risk for
subjects with remote cholecystectomy suggests that this gallbladder
disease also influences pancreatic cancer risk aside from reverse
causality or coincidence.
Discrepant results have also been reported for gallstones. Four
studies revealed a positive association between gallstones and
pancreatic cancer risk (Gullo et al, 1996; Chow et al, 1999;
Coughlin et al, 2000; Lipworth et al, 2011). However, this
association was no longer statistically significant in the two of
those studies when subjects with gallstones diagnosed within
2 years of cancer diagnosis were deleted from analysis (Gullo et al,
1996; Lipworth et al, 2011). In an Italian study, a significantly
increased risk was observed for recently detected gallstones (OR
(95% CI): 3.53 (1.67–7.45)) but not for gallstones detected over
2 years before cancer diagnosis (Lipworth et al, 2011). Our study
found a significant, positive association between presence of
gallstones and risk of pancreatic cancer. We did not consider
timing for the effect of gallstones due to lack of data. However,
timing-related risk estimates for gallstones are expected to be
similar to those of cholecystectomy because 77% of subjects
diagnosed with gallstones underwent cholecystectomy in our study
population. Symptomatic gallstone disease is a common indication
for cholecystectomy (Duca et al, 2003). As cholecystokinin has
trophic effect on the pancreas, it has been put forward that elevated
risk associated with gallstones is ascribed to the increased release of
cholecystokinin following cholecystectomy (Talamini et al, 2001).
After adjustment for cigarette smoking and other risk factors,
tonsillectomy was associated with a significantly reduced risk of
pancreatic cancer in our study. Of the eight studies that have
evaluated this association (Wynder et al, 1973; Lin and Kessler,
1981; Gold et al, 1985; Mack et al, 1986; Mills et al, 1988; Farrow
and Davis, 1990; Bueno de Mesquita et al, 1992; Kalapothaki et al,
1993), six revealed a lower risk associated with tonsillectomy (Lin
and Kessler, 1981; Gold et al, 1985; Mack et al, 1986; Mills et al,
1988; Farrow and Davis, 1990; Bueno de Mesquita et al, 1992), and
the beneficial effect attained statistical significance in three of them
(Lin and Kessler, 1981; Gold et al, 1985; Farrow and Davis, 1990).
It should be mentioned that only two of those previous studies
included adjustment for cigarette smoking (Gold et al, 1985; Bueno
de Mesquita et al, 1990). The reduced risk for tonsillectomy, which
was observed in the present study and some other studies, implies
that alterations in immunity may have a role in pancreatic cancer
etiology (Farrow and Davis, 1990). Toll-like receptors (TLRs)
function in innate immunity by recognising structurally conserved
molecules on microbes. It was found that expression of TLR2,
TLR3, and TLR5 was increased in T cytotoxic (CD8) lymphocytes
derived from recurrently infected tonsils (a main indicator for
tonsillectomy) compared with the CD8 cells from control tonsils
(Mansson et al, 2006). Some changes in humoral immunity were
also observed. One study revealed that parotid salivary immuno-
globulin A was elevated within the first year after tonsillectomy
(Childers et al, 2001). It appears that enhanced immunity may
Table 2. Risk of pancreatic cancer in relation to selected medical conditions in a population-based case-control study in Minnesota, 1994–1998
Condition No. of cases No. of controls Crude OR (95% CI) Adjusted OR (95% CI)a
Cholecystectomy
No 155 604 1.00 (Referent) 1.00 (Referent)
Yes 48 72 2.60 (1.73–3.89) 2.11 (1.32–3.35)
Gallstones
No 151 597 1.00 (Referent) 1.00 (Referent)
Yes 42 78 2.13 (1.40–3.21) 1.97 (1.23–3.12)
Tonsillectomy
No 107 301 1.00 (Referent) 1.00 (Referent)
Yes 100 374 0.75 (0.55–1.03) 0.67 (0.48–0.94)
Abbreviations: CI¼ confidence interval; OR¼odds ratio. All bold ORs statitically significant as indicated by their 95% CIs.
aAdjusted for age, sex, race, smoking status, physical activity, and diabetes.
Table 3. Risk of pancreatic cancer in relation to time since cholecystectomy in a population-based case-control study in Minnesota, 1994–1998
Cholecystectomy No. of cases No. of controls Crude OR (95% CI) Adjusted OR (95% CI)a
None 155 604 1.00 (Referent) 1.00 (Referent)
p2 years 17 8 8.28 (3.61–20.6) 5.93 (2.36–15.7)
3–19 years 10 31 1.26 (0.57–2.53) 1.31 (0.57–2.75)
X20 years 17 32 2.07 (1.10–3.78) 2.27 (1.16–4.32)
Abbreviations: CI¼ confidence interval; OR¼odds ratio. All bold ORs statitically significant as indicated by their 95% CIs.
aAdjusted for age, sex, race, smoking status, physical activity, and diabetes.
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offer some explanations for potential benefit of tonsillectomy,
which gains further support from a pooled analysis of 10 case-
control studies in which a significantly lower risk of pancreatic
cancer was found for subjects with any allergy and some specific
allergies (Olson et al, 2013).
Our study has some advantages over previous studies. The risk
estimates reported in the present study were controlled for most
established and potential confounders. We examined the associa-
tion between cholecystectomy and pancreatic cancer in terms of
time since the diagnosis of this surgical procedure. Such an
approach made it possible for us to evaluate the possibility of
reverse causality.
The present study also has several weaknesses. Recall bias and
selection bias should be always considered in case-control studies.
Recall bias occurs when cases are more or less likely to report
exposure(s) of interest than controls. In contrast to the common
misreporting of dietary and other lifestyle factors (Goris et al, 2000;
Zhang et al, 2000), subjects generally have a relatively accurate
recall of the occurrence of the medical conditions considered in our
analysis, as there was no clear reason for them to misreport
personal history of gallbladder disease. The response rate for both
cases and controls was less than 60%. This suggests that selection
bias might have somewhat distorted our results because it is
possible that respondents differed from non-respondents with
regard to their demographic, socioeconomic, and lifestyle factors.
Detection bias might arise as cases were more likely than
controls to receive abdominal diagnostic examinations (e.g.,
ultrasound, X-ray, and/or CT scan) and thereby to be diagnosed
with asymptomatic gallstones or other gallbladder diseases. Given
the absence of data on the history of these medical examinations
for our study subjects, we are unable to estimate whether and to
what extent the detection bias have influenced our observed results
for gallstones and cholecystectomy. In the present study, cases of
pancreatic cancer were enroled from Midwest residents attending
the Mayo Clinic and from all hospitals in the Twin Cities
metropolitan area with a rapid case-ascertainment system.
Recruitment was also conducted with assistance from Minnesota
Cancer Surveillance System and local tumour registries. These
methods might have biased recruitment towards patients with
early-stage, resectable pancreatic cancer as compared with the total
population of eligible cases. However, ascertaining cases from
population-based cancer registries alone was not feasible owing to
the time needed for physicians to report cancer diagnosis to cancer
registries and the rapid fatality of this malignancy. As 22 cases with
missing data on gallstones were significantly younger and more
likely to be female than 193 cases with data on this gallbladder
disease (data not shown), our reported results might have been
different to some extent if such data were available for those 22
cases and were included in analysis. However, those cases with
missing information were not significantly different in race,
smoking status, physical activity, and diabetes from the other
193 cases.
A relatively small number of cases were enroled in the present
study, and therefore some of our findings may be due to chance.
Body mass index was not measured due to an oversight and thus
was not adjusted as a confounder in our study. Energy intake and
physical activity are main determinants of overweight and obesity.
Physical activity was controlled for in the logistic regression models
from which risk estimates are presented in Tables 2 and 3. As
stated previously, additional adjustment for energy intake did not
materially change our results. Nevertheless, it is possible that our
findings might have been distorted by residual confounding by
body mass index.
In summary, the present study revealed that cholecystectomy
and gallstones are associated with an increased risk of pancreatic
cancer, whereas tonsillectomy is associated with a reduced risk.
The strong association with recent cholecystectomy might be
explained in part by reverse causality or detection bias. More
epidemiologic studies are warranted to further investigate whether
the medical conditions considered in this study are causally
associated with pancreatic cancer risk. Such studies are important
because identifying risk factors helps to formulate the preventive
strategies for this dreadful disease.
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